Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for GALCANEZUMAB
- Efficacy of Flunarizine Vs Amitriptyline in Prophylaxis of Migraine Prophylaxis
- Tandem OnabotulinumtoxinA Galcanezumab Emerging Therapeutic Headache Elimination Research Study
- Real World Effectiveness of Eptinezumab in Participants With Migraine
- A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine
- Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg vs Placebo as Adjuvant Treatment in Chronic Migraine -
- A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
- Galcanezumab for Vestibular Migraine
- A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb CGRP Antagonist
- Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action
- Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine
- Anti-CGRP for Inflamation and Pain Modulation in Small Fiber Neuropathy/Fibromyalgia
- A Study of Galcanezumab (LY2951742) in Healthy Chinese Participants
- A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine
- A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine
- A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
- A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine
- A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic Migraine
- A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
- A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura
- Evaluation of Galcanezumab in the Prevention of Chronic Migraine
- Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
- Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
- A Study of Galcanezumab in Healthy Participants
- A Study of Galcanezumab in Participants With Chronic Cluster Headache
- A Study Of Galcanezumab In Participants With Episodic Cluster Headache
- A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
Clinical trials list
click for details